Tenaya Therapeutics (TNYA) Assets Average (2021 - 2026)

Tenaya Therapeutics' Assets Average history runs 6 years deep, the most recent figure standing at $141.0 million for Q1 2026.

• On a quarterly basis, Assets Average rose 6.86% year-over-year to $141.0 million in Q1 2026; TTM through Mar 2026 was $141.0 million, a 6.86% increase from a year earlier, with the FY2025 full-year figure at $133.4 million, down 8.12% from the prior year.
• Assets Average grew to $141.0 million in Q1 2026 per TNYA's latest filing, from $126.0 million in the prior quarter.
• Across five years, Assets Average topped out at $297.8 million in Q1 2022 and bottomed at $113.6 million in Q3 2025.
• The 5-year median for Assets Average is $177.7 million (2024), against an average of $189.6 million.
• Across the five-year window, Assets Average slumped 32.21% in 2024 and increased 6.86% in 2026, its largest moves.
• Year by year, Assets Average stood at $252.6 million in 2022, then slipped by 27.97% to $182.0 million in 2023, then retreated by 28.41% to $130.3 million in 2024, then declined by 3.31% to $126.0 million in 2025, then grew by 11.95% to $141.0 million in 2026.
• Per Business Quant, the three latest TNYA Assets Average figures stand at $141.0 million (Q1 2026), $126.0 million (Q4 2025), and $113.6 million (Q3 2025).